CD8A and cancer: After the second recurrence, the expression of CD3, CD4, CD8, CD20 and IL-1β increased and the expression of PD-L1 and TCF-1 decreased in the cancer nest after H101 injection (Figures 3, 4; Supplementary Figure 2).